These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1251772)

  • 21. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
    Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].
    Angermann C; Autenrieth G
    Klin Wochenschr; 1981 Jul; 59(14):803-11. PubMed ID: 7265814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias.
    Myers JB; Millar RN; Obel IW
    S Afr Med J; 1978 Dec; 54(26):1083-9. PubMed ID: 746466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute oral antiarrhythmic testing with disopyramide.
    García-Barreto D; Toruncha A; Gonzalez-Gomez A; Llerena L; Groning E; Hernandez-Cañero A
    Clin Cardiol; 1981; 4(6):330-5. PubMed ID: 7326884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog.
    Remme WJ; Verdouw PD; Hagemeyer F
    Eur J Pharmacol; 1976 Mar; 36(1):189-97. PubMed ID: 1261591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of Ritmilen and allapinin on central hemodynamics and myocardial contractility of patients with heart rhythm disorders].
    Asymbekova EU; Bunin IuA; Pomerantsev EV; Firstova MI; Bakashvili NG
    Kardiologiia; 1987 Apr; 27(4):68-71. PubMed ID: 3155396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oral disopyramide therapy on left ventricular function.
    Greene AC; Iskandrian AS; Hakki AH; Kane SA; Segal BL
    Chest; 1983 Mar; 83(3):480-4. PubMed ID: 6825481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.
    Kötter V; Linderer T; Schröder R
    Am J Cardiol; 1980 Sep; 46(3):469-75. PubMed ID: 7415992
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemodynamic effects of disopyramide in patients after open-heart surgery.
    Naqvi N; Thompson DS; Morgan WE; Williams BT; Coltart DJ
    Br Heart J; 1979 Nov; 42(5):587-94. PubMed ID: 316334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of penticainide (CM 7857), a novel class I antiarrhythmic drug--comparison with disopyramide.
    Pfisterer M; Munoz A; Burkart F
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):247-51. PubMed ID: 2459557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function.
    Alpert JS; Benotti JR; Brady PM; McCue JE; Weiner BH; Ockene IS
    Am J Cardiol; 1985 Mar; 55(7):20C-24C. PubMed ID: 3872053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.
    Kimball BP; Bui S; Wigle ED
    Am Heart J; 1993 Jun; 125(6):1691-7. PubMed ID: 8498312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
    Thadani U; Manyari D; Gregor P; Olowoyeye J; Leach A; West RO; Parker JO
    Cathet Cardiovasc Diagn; 1981; 7(1):27-34. PubMed ID: 7214518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantitative evaluation of an antiarrhythmic therapy (disopyramide) in patients with frequent premature ventricular contractions (PVC) using a computer-assisted long-term ECG analysis system (author's transl)].
    Weber H; Gloger D; Joskowicz G; Steinbach K
    Z Kardiol; 1981 Jan; 70(1):13-21. PubMed ID: 7210773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.
    Legrand V; Vandormael M; Collignon P; Kulbertus HE
    Am J Cardiol; 1983 Feb; 51(3):422-6. PubMed ID: 6823856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.